METAPNEUMOVIRUS INFECTION
Clinical trials for METAPNEUMOVIRUS INFECTION explained in plain language.
Never miss a new study
Get alerted when new METAPNEUMOVIRUS INFECTION trials appear
Sign up with your email to follow new studies for METAPNEUMOVIRUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One shot, three viruses? new vaccine trial targets RSV, hMPV, and PIV3 in seniors
⭐️ VACCINE ⭐️ CompletedThis Phase 1 study tests a new vaccine that aims to protect against three respiratory viruses at once: RSV, hMPV, and PIV3. The trial involves 390 adults aged 60 and older and will check if the vaccine is safe and helps the body produce antibodies. Different combinations and dose…
Matched conditions: METAPNEUMOVIRUS INFECTION
Phase: PHASE1 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:23 UTC
-
Double-Duty mRNA vaccine targets RSV and hMPV in early trial
⭐️ VACCINE ⭐️ CompletedThis early-stage trial tested an experimental mRNA vaccine designed to protect against two respiratory viruses: RSV and hMPV. Healthy adults aged 18 to 49 and 60 years and older received a single injection of the vaccine at different doses. The main goals were to check safety and…
Matched conditions: METAPNEUMOVIRUS INFECTION
Phase: PHASE1 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 26, 2026 16:03 UTC